Nincs elég ideje elolvasni a teljes cikket? Hallgassa meg az összefoglalót 2 percben.

Across Europe, medical device manufacturers are still heavily focused on one major regulatory milestone: MDR certification. Technical documentation, clinical evidence, and Notified Body reviews have dominated compliance programs for years.

Yet another transformation is approaching quietly in the background.

From 2026 onward, several modules of EUDAMED, the European Database on Medical Devices, will become mandatory for manufacturers operating under the EU Medical Device Regulation. When that happens, regulatory compliance will shift from periodic documentation submissions to continuous digital reporting.

Many organisations believe they are prepared.

But once companies begin preparing device registrations, UDI uploads, and structured product data for EUDAMED, a different reality often emerges. The challenge is rarely the regulation itself. It is the operational readiness required to function inside a live regulatory data ecosystem.

The Database That Will Redefine Device Regulation

EUDAMED is more than a regulatory platform. It is designed to become the central digital infrastructure of the European medical device market.

The database will connect regulators, manufacturers, notified bodies, distributors, and healthcare providers through a single system. Its purpose is to increase transparency and allow regulators to monitor devices throughout their lifecycle.

Once fully operational, EUDAMED will contain several critical data domains:

• manufacturer registrations
• device registrations
• Unique Device Identification (UDI) records
• clinical investigations
• vigilance reporting
• post-market surveillance data

In practical terms, this means that device manufacturers must maintain accurate, structured regulatory data continuously rather than submitting documentation only during certification cycles.

For many organisations, that represents a fundamental change in how regulatory operations function.

Why EUDAMED Looked Simpler Than It Is

At first glance, EUDAMED appears to be a straightforward reporting platform. Manufacturers register their devices, upload product data, and maintain regulatory records inside the system.

That assumption has proven misleading.

EUDAMED requires companies to maintain highly structured product information that remains consistent across multiple systems. Device identifiers, regulatory documentation, production data, and post-market surveillance information must all align.

For organisations with hundreds or thousands of products, this becomes a complex data governance exercise rather than a simple compliance task.

The difficulty usually appears when companies begin preparing their first large-scale device uploads.

What looked like a regulatory form suddenly becomes a cross-functional data project.

The Four Readiness Gaps Inside Device Manufacturers

When organisations begin preparing for EUDAMED, the same operational gaps tend to appear.

1. Fragmented product data

Product information rarely sits in one place.

Regulatory teams maintain device documentation, ERP systems store product structures, quality databases track compliance records, and local teams often rely on spreadsheets to manage operational details.

EUDAMED requires these datasets to align. When inconsistencies appear, preparing device registrations becomes far more complicated than expected.

2. UDI governance is still immature

Unique Device Identification is one of the foundations of the EUDAMED system.

Each device must be assigned structured identifiers that remain consistent across manufacturing, regulatory documentation, and supply chain traceability. Many companies implemented UDI only recently and are still stabilising the process.

When product hierarchies, identifiers, or packaging structures are not fully aligned, uploading device information into EUDAMED becomes difficult.

3. Regulatory teams cannot solve the problem alone

Many organisations initially assigned EUDAMED preparation to Regulatory Affairs teams. The assumption was that it represented another regulatory reporting obligation.

In reality, EUDAMED touches multiple operational systems:

• product master data
• ERP and IT infrastructure
• supply chain traceability
• quality documentation
• regulatory records

Without coordination between these functions, regulatory teams struggle to gather and structure the data required for submission.

4. Organisational ownership is often unclear

Perhaps the most common readiness gap is governance.

If EUDAMED is treated as a purely regulatory project, progress is slow. When the responsibility expands across product data, IT systems, and operational reporting, companies must establish cross-functional ownership.

Without that coordination, readiness programs tend to stall before the first large device registrations are even completed.

When Companies Realise the Gap

The moment of realisation usually arrives during practical preparation.

Manufacturers begin mapping their product portfolios for registration. They attempt to align UDI identifiers with regulatory documentation. They prepare to upload device data into the EUDAMED structure.

At that point, inconsistencies appear.

Product names differ between systems. Device hierarchies are incomplete. Documentation references no longer match operational data. Regulatory teams discover they cannot submit information until these discrepancies are resolved.

What initially looked like a regulatory formality becomes a significant internal alignment exercise.

How Some Companies Are Stabilising EUDAMED Readiness

The organisations progressing most smoothly through EUDAMED preparation tend to approach the challenge differently. Instead of treating it as a regulatory reporting task, they manage it as a structured operational program.

Several stabilisation approaches are becoming common.

Some companies establish dedicated EUDAMED readiness programs that coordinate regulatory, IT, and product data teams. Others begin by prioritising high-value product portfolios rather than attempting to upload every device simultaneously.

Another important step involves strengthening product data governance, ensuring that identifiers, product hierarchies, and regulatory records remain consistent across systems.

In complex organisations, companies sometimes bring in additional senior regulatory or operatív vezetés temporarily to coordinate the program and accelerate readiness across departments.

The key shift is simple: EUDAMED preparation moves from compliance administration to organisational execution.

The Beginning of Continuous Regulatory Data

EUDAMED signals a broader change in how medical device regulation operates in Europe.

Historically, compliance relied on documentation reviews during certification cycles. Under MDR and EUDAMED, regulators are building a system that allows ongoing monitoring of devices across their lifecycle.

For manufacturers, this means regulatory operations must become more data-driven and integrated with product governance, manufacturing systems, and supply chain traceability.

Companies that recognise this shift early will adapt their operating models accordingly.

Those that underestimate the operational implications may discover that preparing for EUDAMED is far more demanding than they expected.